Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Deloitte
US Department of Justice
Farmers Insurance
Cerilliant
Argus Health
Johnson and Johnson
Cipla

Generated: May 23, 2018

DrugPatentWatch Database Preview

ERYTHROCIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Erythrocin, and what generic alternatives are available?

Erythrocin is a drug marketed by Abbott, Hospira, and Arbor Pharms Llc. and is included in five NDAs.

The generic ingredient in ERYTHROCIN is erythromycin stearate. There are one hundred and two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Drug patent expirations by year for ERYTHROCIN
Pharmacology for ERYTHROCIN
Synonyms for ERYTHROCIN
1334-29-8
1334-39-0
33H58I7GLQ
3847-29-8
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin (1:1)
847E298
AC1L2G7Z
AC1Q5R2M
Azithromycin lactobionate
C37H67NO13.C12H22O12
C49H89NO25
CA000798
CHEMBL1200506
CHEMBL3786307
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1)
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1) (9CI)
D02009
EINECS 223-348-7
Erythrocin Lactobionate IV
Erythromycin 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
erythromycin lactobionate
Erythromycin lactobionate (1:1) (salt)
Erythromycin lactobionate (JP17/USP)
Erythromycin lactobionate [JAN]
Erythromycin mono(4-O-beta-D-galactopyranosyl-D-gluconate) (salt)
Erythromycin, 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
ERYTHROMYCIN; LACTOBIONIC ACID
Erythromycin. compd. with lactobionic acid
ERYTHROMYCINLACTOBIONATE
Lactobionic acid compd. with erythromycin (1:1)
Lactobionic acid, compd. with erythromycin (1:1)
LS-87509
MolPort-039-062-122
n-2,10-dion(1:1)
Q-201067
SCHEMBL41566
UNII-33H58I7GLQ

US Patents and Regulatory Information for ERYTHROCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 062586-002 Jan 4, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 050182-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 050182-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 050609-001 Sep 24, 1986 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Chubb
Baxter
Boehringer Ingelheim
AstraZeneca
Merck
UBS
Moodys
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.